Molecular and Cellular Immunology Core
Sidebar
The Molecular and Cellular Immunology (MCI) Core launched in April 2023. It was established to include the former SD CFAR Flow Cytometry and Genomics and Sequencing Cores as well as expanded to include single-cell -omics services and expertise.
The MCI Core streamlines services and facilitates HIV research by centralizing technical expertise, training and major instrumentation for our members. The MCI Core combines resources and key services offered by the former SD CFAR Flow Cytometry and Genomics and Sequencing Cores with added capabilities from infrastructure at Scripps Research via the Burton and Briney Labs. Projects previously served by the Flow Cytometry and Genomics and Sequencing Cores will continue to be supported by the MCI Core.
The MCI Core offers cutting edge technologies to CFAR members, including specialized flow cytometry equipment for cell sorting (including biohazardous) and analysis, several sequencing platforms (e.g., MiSeq, NovaSeq 6000, HiSeq PacBio SMRT, Nanopore, Ion S5/Ion Chef) and qPCR platforms (e.g., Taqman, droplet digital PCR).
The Molecular and Cellular Immunology Core is comprised of three units:
MCI Core services are offered at various locations across UC San Diego (Stein), Scripps Research, and the VA San Diego Healthcare System. In some cases, services are offered at more than one location and investigators can select the laboratory that best fits their needs.
Investigators may request multiple services across units from the MCI Core Service Request Form. MCI Core units will collaborate as your project moves through the various stages serviced by each of the units.
MCI Core Service Flow
.png){kind=logo}
